1. |
Verhoest G, Delreux A, Mathieu R, et al. Transperitoneal laparoscopic nephrectomy for autosomal dominant polycystic kidney disease. JSLS, 2012, 16(3):437-442.
|
2. |
Seshadri PA, Poulin EC, Pace D, et al. Transperitoneal laparoscopic nephrectomy for giant polycystic kidneys:a case control study. Urology, 2001, 58(1):23-27.
|
3. |
Menezes LF, Zhou F, Patterson AD, et al. Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4alpha as a disease modifier. PLoS Genet, 2012, 8(11):e1003053.
|
4. |
Chang MY, Ong AC. Mechanism-based therapeutics for autosomal dominant polycystic kidney disease:recent progress and future prospects. Nephron Clin Pract, 2012, 120(1):c25-34; discussion c35.
|
5. |
Dunn MD, Portis AJ, Elbahnasy AM, et al. Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease. Am J Kidney Dis, 2000, 35(4):720-725.
|
6. |
Xue C, Nie W, Xu J, et al. C509T and T869C polymorphisms of transforming growth factor beta1 and the risk of IgA nephropathy:a meta-analysis. Chin Med J (Engl), 2013, 126(23):4562-4567.
|
7. |
Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315(7109):629-634.
|
8. |
Gill IS, Kaouk JH, Hobart MG, et al. Laparoscopic bilateral synchronous nephrectomy for autosomal dominant polycystic kidney disease:the initial experience. J Urol, 2001, 165(4):1093-1098.
|
9. |
Patel P, Horsfield C, Compton F, et al. Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl, 2011, 93(5):391-395.
|
10. |
Eng M, Jones CM, Cannon RM, et al. Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS, 2013, 17(2):279-284.
|
11. |
Desai MR, Nandkishore SK, Ganpule A, et al. Pretransplant laparoscopic nephrectomy in adult polycystic kidney disease:a single centre experience. BJU Int, 2008, 101(1):94-97.
|
12. |
Sathiyakumar V, Molina CS, Thakore RV, et al. ASA Score as a Predictor of 30-Day Perioperative Readmission in Patients With Orthopaedic Trauma Injuries:An NSQIP Analysis. J Orthop Trauma, 2015, 29(3):e127-132.
|
13. |
Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet, 2007, 369(9569):1287-1301.
|
14. |
Bennett AH, Stewart W, Lazarus JM. Bilateral nephrectomy in patients with polycystic renal disease. Surg Gynecol Obstet, 1973, 137(5):819-820.
|
15. |
Takakura A, Nelson EA, Haque N, et al. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet, 2011, 20(21):4143-4154.
|
16. |
Bansal RK, Kapoor A. Laparoscopic nephrectomy for massive polycystic kidney disease:Updated technique and outcomes. Can Urol Assoc J, 2014, 8(9-10):341-345.
|
17. |
Serra AL, Kistler AD, Poster D, et al. Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease, in Nephrology, dialysis, transplantation:official publication of the European Dialysis and Transplant Association-European Renal Association, 2009, pp. 3334-3342.
|
18. |
Wisenbaugh ES, Tyson MD 2nd, Castle EP, et al. Massive renal size is not a contraindication to a laparoscopic approach for bilateral native nephrectomies in autosomal dominant polycystic kidney disease (ADPKD). BJU Int, 2014, 115(5):796-801.
|
19. |
Tellman MW, Bahler CD, Shumate AM, et al. Management of pain in autosomal dominant polycystic kidney disease and anatomy of renal innervation. J Urol, 2015, 193(5):1470-1478.
|
20. |
Xue C, Dai B, Mei C. Long-term treatment with mammalian target of rapamycin inhibitor does not benefit patients with autosomal dominant polycystic kidney disease:a meta-analysis. Nephron Clin Pract, 2013, 124(1-2):10-16.
|